Key facts
- This page summarizes David A. Montecalvo's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 24 Feb 2022, 15:54.
David A. Montecalvo - 22 Feb 2022 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)
- Reporting relationship
- SVP, Glob Ops and Supply Chain
- Issuer ticker
- WST
- Reported as of
- 22 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2022, 15:54:26 UTC
- Prior SEC filing
- 14 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- Ryan Metz as Agent for David A. Montecalvo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David A. Montecalvo filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 24 Feb 2022.
Change
- Previous filing in this sequence was filed on 14 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WST
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +2,848
- Change %
- Price
- $0.000000
- Shares after
- 2,848
- Date
- 22 Feb 2022
- Ownership
- Direct
- Underlying class
- Stock Options (Right to Buy)
- Underlying amount
- 2,848
- Exercise price
- $369.13
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This award vests in four equal annual installments beginning on February 22, 2023.